Todd S. Young - Feb 1, 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President and Chief Financial Officer
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for Todd S. Young
Stock symbol
ELAN
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/3/2023, 03:06 PM
Previous filing
Mar 3, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Conversion of derivative security +1.56K +31.24% 6.56K Feb 1, 2023 By IRA F1
holding ELAN Common Stock 120K Feb 1, 2023 Direct
holding ELAN Common Stock 2K Feb 1, 2023 By J. G. Young IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Tangible Equity Units Conversion of derivative security $0 -1.56K -100% $0.00* 0 Feb 1, 2023 Common Stock 1.56K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Tangible Equity Unit ("TEU") included a prepaid stock purchase contract that automatically settled on February 1, 2023 for 1.5625 shares of the Issuer's common stock.

Remarks:

Executive Vice President and Chief Financial Officer